Search

Your search keyword '"Ochiai, atsushi"' showing total 2,216 results

Search Constraints

Start Over You searched for: Author "Ochiai, atsushi" Remove constraint Author: "Ochiai, atsushi"
2,216 results on '"Ochiai, atsushi"'

Search Results

201. Transoral surgery for superficial head and neck cancer: National Multi‐Center Survey in Japan

202. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine

203. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine

206. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer

210. Detection of desmoplastic reaction in biopsy specimens is useful for predicting the depth of invasion of early colorectal cancer: a Japanese collaborative study

217. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses

218. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma

219. Prognostic impact of the tumor immune microenvironment in pulmonary pleomorphic carcinoma

220. Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate

221. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation

223. Additional file 4 of Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction model

227. Su1103 ASSESSMENT OF ELASTIC LAMINAL INVASION CONTRIBUTE TO MORE OBJECTIVE PATHOLOGICAL T CLASSIFICATION IN COLON CANCER

237. PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer.

244. Downregulation of Immune Response- and External Stimulus-Related Genes in CRC Organoids, and Their Re-Expression by Co-Culturing with CAFs

Catalog

Books, media, physical & digital resources